🇺🇸 FDA
Patent

US 12162910

Recombinant gp120 protein with V1-loop deletion

granted A61KA61K38/00A61K39/21

Quick answer

US patent 12162910 (Recombinant gp120 protein with V1-loop deletion) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K39/21, A61P, A61P31/18